The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A

This study aimed to determine the long-term quality of life (QoL) in hemifacial spasm (HFS) patients after treating with Abo-botulinum toxin A (Abo-BTX). The study assessed the disease-specific QoL (hemifacial spasm questionnaire 30 items; HFS 30), the involuntary movements (abnormal involuntary mov...

Descripción completa

Detalles Bibliográficos
Autores principales: Kongsaengdao, Subsai, Maneeton, Narong, Maneeton, Benchalak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999068/
https://www.ncbi.nlm.nih.gov/pubmed/33809486
http://dx.doi.org/10.3390/toxins13030215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999068/
https://www.ncbi.nlm.nih.gov/pubmed/33809486
http://dx.doi.org/10.3390/toxins13030215

Ejemplares similares